A study to better understand the association between Lipoprotein(a), Lp(a) levels and artherosclerotic cardiovascular disease (ASCVD) in an underrepresented population has been announced by Amgen, which will collaborate with the Association of Black Cardiologists and the Morehouse School of Medicine on theĀ African American Heart Study.